Skip to main content
All Posts By

Recuro Health

Patients
September 7, 2021

Why telehealth, boosted by the pandemic, could revolutionize health care

Why telehealth, boosted by the pandemic, could revolutionize health care By Mitchell Schnurman, It’s a convenient, cost-effective way to reach underserved communities, and it’s a key part of the billions being invested in emerging digital health companies. Telehealth has been around for decades, but the pandemic pushed it into the mainstream, and it’s now growing in many directions. Up to 17%…
Clients
August 25, 2021

At-Home Covid-19 Testing Solution: Empowering Employers To Provide A Safe Workplace

Choosing the right solution to help employees safely return-to-work The surge of the Delta variant and recurrence of disease even among those who have been vaccinated, coupled with lower-than-expected vaccination rates and concerns about the need for booster injections, are fueling the need for ”testing often,” as a key to stopping the virus spread. A safe return to work continues…
BlogClients
August 25, 2021

Recuro’s At-Home & Onsite COVID Testing Solution Can Ensure Workplace Safety as Delta Variant Cases Grow 

Recuro’s At-Home & Onsite COVID Testing Solution Can Ensure Workplace Safety as Delta Variant Cases Grow  The Centers for Disease Control and Prevention (CDC) estimates that the Delta variant represents about 99% of new COVID-19 infections. As a result, there is a sharp, increased demand for COVID At-Home or Onsite Testing solutions. Employers recognize that frequent or ongoing testing can…
ClientsPress Release
August 25, 2021

Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth

Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth DALLAS—(BUSINESS WIRE)—Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces a $15 million Series A financing…
Clients
August 11, 2021

Teladoc Founder’s Startup Brings Patient Monitoring Home

Teladoc Founder’s Startup Brings Patient Monitoring Home By Dane Hamilton Michael Gorton, who co-founded and led Teladoc Health two decades ago, is betting his next venture, Recuro Health, is going to be as transformative to the healthcare delivery system as Teladoc, a now-$23 billion company which set off a wave of innovation in the telehealth space in recent years. The Dallas-based startup, which is…
Clients
August 9, 2021

A Conversation with Michael Brombach, Chief Product Officer at Recuro Health and founder of SupDoc

A Conversation with Michael Brombach, Chief Product Officer at Recuro Health and founder of SupDoc Join us for a conversation with Frank Jaskulke and Michael Brombach, the founder of SupDoc and Chief Product Officer of Recuro. Hear form Michael to learn how SupDoc, an AI-powered health platform, is helping to innovate virtual care and learn what makes SupDoc different from…
PatientsPress Release
August 2, 2021

Vaccinate or Get Tested: Federal & State Governments, CDC, Corporations Issue New Directives as Delta Variant Fuels Demand for Recuro COVID At-Home or Onsite Testing Platform

Vaccinate or Get Tested: Federal & State Governments, CDC, Corporations Issue New Directives as Delta Variant Fuels Demand for Recuro COVID At-Home or Onsite Testing Platform DALLAS—(BUSINESS WIRE)—Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, reports sharp, increased employer demand for at-home or on site COVID testing to…
BlogClients
August 2, 2021

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution ‘Vaccinate or Get Tested’ is the new policy from all corners of government and private industry amid the surge of the Delta variant, recurrence of disease even among those who have been vaccinated and a plateau in…
Clients
July 28, 2021

Spotlight Interview: John Halsey, Chief Growth Officer, Recuro & Michael Brombach, Executive Director, Recuro

Spotlight Interview: John Halsey, Chief Growth Officer, Recuro & Michael Brombach, Executive Director, Recuro Medical Travel Digital Health News (MTDHN): First, tell our readers why Recuro’s COVID-19 PCR rapid testing is a vital component of every employer’s back-to-work strategy – what are the key issues that employers should be looking at? The follow up to this discussion is Recuro’s role…
BlogClientsPatients
July 26, 2021

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference Allison Martin, a founder and executive director of Recuro Health, recently joined a panel at the American Telemedicine Association’s annual conference to talk about emerging tech for lingering gaps in virtual care and exploring remote testing and diagnostics in the home. Recuro’s at-home diagnostic…